CLU and lung cancer: Consistent with previous reports showing that the treatment of the ROCK1 inhibitor Y27632 markedly inhibits the invasion and migration of breast cancer cells in vitro and bone metastases in vivo [15], our study demonstrates that Y27632 also inhibits the migration of lung cancer cells, especially those silenced with CLU expression.